
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Proteomics International Laboratories Limited is a biotechnology business based in Australia. Proteomics International Laboratories shares (PIQ) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Proteomics International Laboratories has a trailing 12-month revenue of around $2.7 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.195 - $0.845 |
---|---|
50-day moving average | $0.7491 |
200-day moving average | $0.5943 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.026 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.76 on 2021-01-22
1 week (2021-01-16) | N/A |
---|---|
1 month (2020-12-24) | -1.30% |
3 months (2020-10-23) | 27.73% |
6 months (2020-07-24) | 46.15% |
1 year (2020-01-24) | 153.33% |
---|---|
2 years (2019-01-25) | 145.16% |
3 years (2018-01-25) | 130.30% |
5 years (2016-01-25) | 176.36% |
Revenue TTM | $2.7 million |
---|---|
Gross profit TTM | $1.9 million |
Return on assets TTM | -27.36% |
Return on equity TTM | -46.98% |
Profit margin | -63.9% |
Book value | 0.048 |
Market capitalisation | $79.7 million |
TTM: trailing 12 months
We're not expecting Proteomics International Laboratories to pay a dividend over the next 12 months.
Over the last 12 months, Proteomics International Laboratories 's shares have ranged in value from as little as $0.195 up to $0.845. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Proteomics International Laboratories 's is 0.7089. This would suggest that Proteomics International Laboratories 's shares are less volatile than average (for this exchange).
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma, the primary common form of oesophageal cancer in Australia. The company was founded in 2001 and is based in Perth, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.